Description
The abstract reports dramatically different IC50 values (402 nM vs 4220 nM) for JQ1 between two medulloblastoma cell lines, but provides no mechanistic explanation. Understanding this differential sensitivity could reveal biomarkers for patient stratification and optimize treatment selection.
Gap type: unexplained_observation Source paper: ApoE mimetic peptide targeted nanoparticles carrying a BRD4 inhibitor for treating Medulloblastoma in mice. (2020, Journal of controlled release : official journal of the Controlled Release Society, PMID:32380205)